Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback